Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized contolled trial. The PAHFRAC-01 project

Autor: Bernabeu-Wittel Máximo, Aparicio Reyes, Romero Manuel, Murcia-Zaragoza José, Monte-Secades Rafael, Rosso Clara, Montero Abelardo, Ruiz-Cantero Alberto, Melero-Bascones María

Publikováno v: BMC Musculoskeletal Disorders, Vol 13, Iss 1, p 27 (2012)

Abstract Background Around one third to one half of patients with hip fractures require red-cell pack transfusion. The increasing incidence of hip fracture has also raised the need for this scarce resource. Additionally, red-cell pack transfusions ar

Externí odkaz: https://doaj.org/article/14395f5a6af54e5d9884d9caec85ca13

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized contolled trial. The PAHFRAC-01 project

Autor: Bernabeu Wittel, Máximo, Aparicio, Reyes, Romero, Manuel, Murcia Zaragoza, José, Monte Secades, Rafael, Rosso, Clara, Montero Saez, Abelardo, Ruiz Cantero, Alberto, Melero Bascones, María, PAHFRAC-01 investigators

Publikováno v: Recercat. Dipósit de la Recerca de Catalunya
instname
BMC Musculoskeletal Disorders, Vol 13, Iss 1, p 27 (2012)
Dipòsit Digital de la UB
Universidad de Barcelona
BMC Musculoskeletal Disorders

Background Around one third to one half of patients with hip fractures require red-cell pack transfusion. The increasing incidence of hip fracture has also raised the need for this scarce resource. Additionally, red-cell pack transfusions are not wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f671bd51838a4043816bab18a755d08
http://hdl.handle.net/2445/126533